Skip to main content
. 2013 Jul 8;8(7):e69462. doi: 10.1371/journal.pone.0069462

Table 4. Study conclusions by funding source.

Conclusion by prevention category Industry sponsored Non-industry sponsored* P-value
Primary prevention (n=43)
Favourable 24 8 <0.0001
Unfavourable/neutral 0 11
Secondary prevention (n=46)
Favourable 30 14 0.2221
Unfavourable/neutral 0 2
All (n=89)
Favourable 54 22 <0.0001
Unfavourable/neutral 0 13
*

Includes non-profit, no funding and/or no disclosure.